VRS
RARE icon

Virginia Retirement Systems’s Ultragenyx Pharmaceutical RARE Stock Holding History

Virginia Retirement Systems’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
31,019
+4,300
+16% +$107K 0.01% 742
2026
Q1 		$560K Buy
26,719
+6,600
+33% +$149K ﹤0.01% 735
2025
Q4 		$463K Buy
20,119
+6,350
+46% +$209K ﹤0.01% 775
2025
Q3 		$414K Sell
13,769
-5,900
-30% -$177K ﹤0.01% 783
2025
Q2 		$715K Sell
19,669
-300
-2% -$10.8K ﹤0.01% 672
2025
Q1 		$723K Buy
+19,969
New +$831K 0.01% 651
2023
Q3 		$510K Buy
14,300
+3,500
+32% +$139K 0.01% 691
2023
Q2 		$498K Buy
10,800
+900
+9% +$41.7K ﹤0.01% 719
2023
Q1 		$397K Buy
9,900
+4,300
+77% +$185K ﹤0.01% 807
2022
Q4 		$259K Sell
5,600
-500
-8% -$19.7K ﹤0.01% 1007
2022
Q3 		$253K Buy
+6,100
New +$313K ﹤0.01% 991
2022
Q1 		$763K Sell
10,500
-3,400
-24% -$237K 0.01% 731
2021
Q4 		$1.17M Buy
13,900
+1,600
+13% +$130K 0.01% 617
2021
Q3 		$1.11M Buy
12,300
+2,100
+21% +$190K 0.01% 580
2021
Q2 		$973K Sell
10,200
-200
-2% -$20.8K 0.01% 659
2021
Q1 		$1.18M Buy
10,400
+1,800
+21% +$245K 0.01% 597
2020
Q4 		$1.19M Buy
8,600
+4,800
+126% +$569K 0.01% 553
2020
Q3 		$312K Buy
3,800
+1,000
+36% +$82.9K ﹤0.01% 918
2020
Q2 		$219K Buy
+2,800
New +$185K ﹤0.01% 1015

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Virginia Retirement Systems's RARE Position: Q2 2026 in Review

Virginia Retirement Systems increased its Ultragenyx Pharmaceutical (RARE) stake by 16% in Q2 2026, buying an estimated $107K and bringing the position to 31,019 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #742.

Virginia Retirement Systems first reported a position in RARE in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.19M in Q4 2020. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Virginia Retirement Systems held 31,019 shares of Ultragenyx Pharmaceutical worth $1.04M as of Q2 2026.
  • Virginia Retirement Systems bought 4,300 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $107K.
  • Ultragenyx Pharmaceutical made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #742 holding.
  • Virginia Retirement Systems first reported a position in Ultragenyx Pharmaceutical in Q2 2020 and has held it in 19 quarters since.
  • Virginia Retirement Systems's Ultragenyx Pharmaceutical position peaked at $1.19M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.